drug

inhaled Loxapine 1.25 mg

as of 2026-07-01
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Alexza Pharmaceuticals, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)

Trials

1
Staccato Loxapine Single Dose PK
NCT00444028Phase 1Completed

KOLs & investigators

1

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
indication
indication
indication
KOL
Randall Stoltz, MD
KOL score —
person